Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
"Oral antibiotic + oral rinse" refers to a specific antimicrobial combination regimen investigated by Augusta University for the treatment of chronic periodontitis. This regimen consists of two systemic antibiotics, amoxicillin (a beta-lactam) and metronidazole (a nitroimidazole), administered orally, alongside a topical chlorhexidine antiseptic oral rinse. Amoxicillin works by inhibiting penicillin-binding proteins, thereby disrupting bacterial cell wall synthesis. Metronidazole is a prodrug that, upon reduction in anaerobic bacteria, forms reactive intermediates that cause DNA strand breakage. Chlorhexidine is a broad-spectrum antiseptic that disrupts microbial cell membranes. This triple-combination approach is used as an adjunct to scaling and root planing (SRP) to reduce the bacterial load and modulate the systemic inflammatory response, specifically targeting the activation of blood myeloid dendritic cells (mDCs) and the Treg-Th17 balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amoxicillin + metronidazole + chlorhexidine.